References
- 1. McCullough J. Blood groups. In: McCullough J, editor. Transfusion Medicine. 2nd ed. Philadelphia: Elsevier; 2005. p. 181-219.
- 2. Mollison PL. Immunology of leucocytes, platelets and plasma components. In: Mollison PL, editor. Blood Transfusions in Clinical Medicine. 11th ed. Malden, Mass: Blackwell Publishing; 2005, p. 546-610.
- 3. Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomaki R, et al. Nomenclature of human platelet antigens. Vox Sanguinis. 2003 Oct;85(3):240-245. DOI: 10.1046/j.1423-0410.2003.00331.x
- 4. McCullough J. Clinical uses of blood components. In: McCullough J, editor. Transfusion Medicine. 2nd ed. Philadelphia: Elsevier; 2005. p. 251-307.
- 5. Valsami S, Dimitroulis D, Gialeraki A, Chimonidou M, Politou M. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility. Asian J Transfus Sci. 2015 Jul- Dec;9(2):117-23. DOI: 10.4103/0973-6247.162684
- 6. Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis. RBC Filtration and Allogeneic Blood Transfusion. Available at: http://www.nataonline.com/np/147/rbc-filtration-and-allogeneic-blood-transfusion [cited on 03.apr.2017]
- 7. Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet refractoriness - practical approaches and ongoing dilemmas in patient management. Br J Haematol. 2015 Nov;171(3):297-305. DOI: 10.1111/bjh.13597
- 8. Cowan K. Strategies to reduce inappropriate use of platelet transfusions. Nursing Times [online]. 2017;113(2):18-21.
- 9. Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, et al. Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review. Transfusion. 2014 Apr;54(4):1180-91. DOI: 10.1111/trf.12395
- 10. Heikal NM, Smock KJ. Laboratory testing for platelet antibodies. Am J Hematol. 2013 Sep;88(9):818-21. DOI: 10.1002/ajh.23503